| Literature DB >> 27297022 |
Shi Song Rong1, Li Jia Chen1,2, Christopher K S Leung1, Kenji Matsushita3, Liyun Jia4, Atsuya Miki3, Sylvia W Y Chiang1, Pancy O S Tam1, Noriyasu Hashida3, Alvin L Young2, Motokazu Tsujikawa3, Mingzhi Zhang5, Ningli Wang4, Kohji Nishida3, Chi Pui Pang1,2,5.
Abstract
A single-nucleotide polymorphism (SNP) rs4236601 at the CAV1/CAV2 locus is associated with primary open-angle glaucoma (POAG). Rs4236601 is common in Caucasians but rare in East Asians. Here we conducted a haplotype-tagging SNP analysis followed by replication in a total of 848 POAG cases and 1574 controls drawn from 3 cities in China and 1 city in Japan. Two SNPs, rs4236601 (odds ratio [OR] = 6.25; P = 0.0086) and a tagging-SNP rs3801994 (OR = 1.32; P = 0.042), were associated with POAG in the Hong Kong Chinese cohort after age and gender adjustments. Rs4236601 was associated with POAG also in Shantou (OR = 6.09; P = 0.0037) and Beijing (OR = 3.92; P = 0.030) cohorts after age and gender adjustment, with a pooled-OR of 5.26 (P = 9.0 × 10(-6)) in Chinese; but it is non-polymorphic in the Osaka cohort. SNP rs3801994 showed a similar trend of effect in the Shantou and Beijing cohorts, with a pooled-OR of 1.23 (P = 0.022) and 1.20 (P = 0.063) in Chinese, prior to and after age and gender adjustment, respectively; but it showed a reverse effect in the Osaka cohort (OR = 0.58; P = 0.033) after the adjustments. We have thus confirmed the association of rs4236601 with POAG in different Chinese cohorts. Also, we found a common SNP rs3801994 of diverse associations with POAG between Chinese and Japanese.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27297022 PMCID: PMC4906515 DOI: 10.1038/srep27837
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic features of the study subjects.
| Phenotype | Sample size | Age (year) | Gender (Male%) |
|---|---|---|---|
| Chinese - Hong Kong | |||
| POAG | 454 | 62 ± 15 | 61.2% |
| Control | 436 | 74 ± 8 | 42.1% |
| Chinese – Shantou | |||
| POAG | 123 | 50 ± 21 | 75.6% |
| Control | 731 | 72 ± 8 | 50.0% |
| Chinese – Beijing | |||
| POAG | 170 | 39 ± 16 | 79.4% |
| Control | 200 | 69 ± 6 | 50.0% |
| Japanese – Osaka | |||
| POAG | 101 | 66 ± 11 | 54.5% |
| Control | 207 | 43 ± 16 | 32.5% |
POAG: primary open-angle glaucoma.
aSignificantly different from control group (P < 0.05).
Allelic association of the CAV1/CAV2 SNPs with POAG.
| SNP | Predicted function | MA | MAF | POAG vs. control | POAG vs. control | |||
|---|---|---|---|---|---|---|---|---|
| Control | POAG | P | OR (95% CI) | P | OR (95% CI) | |||
| Chinese-Hong Kong | ||||||||
| rs1052990 | c.*2195T > G | G | 0.12 | 0.15 | 0.054 | 1.32 (0.99–1.75) | 0.065 | 1.33 (0.98–1.79) |
| rs6466579 | Intergenic | T | 0.18 | 0.19 | 0.52 | 1.08 (0.85–1.37) | 0.46 | 1.10 (0.85–1.42) |
| rs7801950 | Intergenic | T | 0.12 | 0.14 | 0.22 | 1.19 (0.90–1.58) | 0.21 | 1.21 (0.90–1.62) |
| rs4236601 | Intergenic | A | 0.0043 | 0.02 | 4.72 (1.36–16.36) | 6.25 (1.60–24.50) | ||
| rs3779512 | c.102 + 4320T > G | T | 0.061 | 0.056 | 0.68 | 0.92 (0.62–1.37) | 0.93 | 0.98 (0.65–1.49) |
| rs3807989 | c.103-12759A > G | A | 0.22 | 0.25 | 0.083 | 1.21 (0.97–1.51) | 0.11 | 1.21 (0.96–1.53) |
| rs3801994 | c.103-8531G > A | A | 0.15 | 0.18 | 1.31 (1.02–1.69) | 1.32 (1.01–1.74) | ||
| rs1049337 | c.*1246C > T | C | 0.46 | 0.49 | 0.21 | 1.13 (0.93–1.36) | 0.091 | 1.19 (0.97–1.46) |
| Chinese – Shantou | ||||||||
| rs4236601 | Intergenic | A | 0.0049 | 0.02 | 4.23 (1.33–13.43) | 6.09 (1.80–20.63) | ||
| rs3801994 | c.103-8531G > A | A | 0.19 | 0.21 | 0.44 | 1.14 (0.82–1.59) | 0.54 | 1.11 (0.80–1.54) |
| Chinese – Beijing | ||||||||
| rs4236601 | Intergenic | A | 0.013 | 0.036 | 0.057 | 2.86 (0.92–8.85) | 3.92 (0.71–21.49) | |
| rs3801994 | c.103-8531G > A | A | 0.19 | 0.2 | 0.67 | 1.09 (0.72–1.66) | 0.85 | 1.04 (0.49–2.20) |
| Japanese – Osaka | ||||||||
| rs1052990 | c.*2195T > G | G | 0.25 | 0.19 | 0.11 | 0.71 (0.47–1.08) | 0.55 (0.32–0.94) | |
| rs4236601 | Intergenic | – | – | – | – | – | – | – |
| rs3801994 | c.103-8531G > A | A | 0.33 | 0.28 | 0.22 | 0.79 (0.55–1.15) | 0.58 (0.35–0.96) | |
CAV1: caveolin 1; CAV2: caveolin 2; CI: confidence interval; OR: odds ratio; MA: minor allele; MAF: minor allele frequency; POAG: primary open-angle glaucoma; SNP: single-nucleotide polymorphism.
aOutcomes adjusted for age and gender.
Figure 1Association of rs4236601 with primary open-angle glaucoma.
(A) Meta-analysis using unadjusted odds ratios (ORs); (B) Meta-analysis using adjusted ORs.
Figure 2Association of rs3801994 with primary open-angle glaucoma.
(A) Meta-analysis using unadjusted odds ratios (ORs) (B) Meta-analysis using adjusted ORs.
Allelic association of the CAV1/CAV2 SNPs with POAG in males and females.
| SNP | MA | Male | Female | Breslow-day test | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| MAF Control | MAF POAG | P | OR (95% CI) | MAF Control | MAF POAG | P | OR (95% CI) | |||
| Chinese - Hong Kong | ||||||||||
| rs1052990 | G | 0.12 | 0.16 | 0.16 | 1.34 (0.89–2.02) | 0.12 | 0.14 | 0.30 | 1.24 (0.82–1.88) | 0.85 |
| rs6466579 | T | 0.19 | 0.21 | 0.51 | 1.12 (0.80–1.58) | 0.18 | 0.17 | 0.86 | 0.97 (0.68–1.38) | 0.70 |
| rs7801950 | T | 0.12 | 0.14 | 0.28 | 1.25 (0.83–1.88) | 0.12 | 0.13 | 0.66 | 1.10 (0.73–1.65) | 0.69 |
| rs4236601 | A | 0.0034 | 0.017 | 0.083 | 5.21 (0.65–41.87) | 0.005 | 0.024 | 4.94 (1.02–23.94) | 0.65 | |
| rs3779512 | T | 0.072 | 0.063 | 0.61 | 0.87 (0.51–1.49) | 0.054 | 0.045 | 0.58 | 0.84 (0.45–1.57) | 0.95 |
| rs3807989 | A | 0.22 | 0.27 | 0.078 | 1.33 (0.97–1.84) | 0.22 | 0.23 | 0.8 | 1.04 (0.76–1.44) | 0.45 |
| rs3801994 | A | 0.15 | 0.19 | 0.079 | 1.39 (0.96–2.02) | 0.15 | 0.17 | 0.36 | 1.19 (0.82–1.72) | 0.67 |
| rs1049337 | C | 0.46 | 0.48 | 0.61 | 1.07 (0.82–1.41) | 0.46 | 0.51 | 0.18 | 1.20 (0.92–1.58) | 0.67 |
| Chinese - Shantou | ||||||||||
| rs4236601 | A | 0.0014 | 0.016 | 11.72 (1.21–113.30) | 0.0084 | 0.033 | 0.067 | 4.06 (0.80–20.55) | 0.70 | |
| rs3801994 | A | 0.19 | 0.23 | 0.33 | 1.21 (0.82–1.79) | 0.19 | 0.17 | 0.67 | 0.86 (0.43–1.74) | 0.56 |
| Chinese - Beijing | ||||||||||
| rs4236601 | A | 0.016 | 0.019 | 0.81 | 1.19 (0.28–5.03) | 0.01 | 0.057 | 5.76 (1.03–32.16) | 0.56 | |
| rs3801994 | A | 0.2 | 0.23 | 0.46 | 1.19 (0.75–1.87) | 0.18 | 0.15 | 0.57 | 0.80 (0.37–1.73) | 0.49 |
| Japanese - Osaka | ||||||||||
| rs1052990 | G | 0.27 | 0.19 | 0.14 | 0.63 (0.34–1.16) | 0.23 | 0.18 | 0.34 | 0.75 (0.41–1.36) | 0.78 |
| rs4236601 | A | – | – | – | – | – | – | – | – | – |
| rs3801994 | A | 0.38 | 0.31 | 0.23 | 0.72 (0.42–1.23) | 0.3 | 0.24 | 0.24 | 0.72 (0.42–1.24) | 0.99 |
CAV1: caveolin 1; CAV2: caveolin 2; CI: confidence interval; MA: minor allele; MAF: minor allele frequency; OR: odds ratio; POAG: primary open-angle glaucoma; SNP: single-nucleotide polymorphism.
aBreslow-day test was performed using Taron adjustment.